Product Information
PRILOSEC DR 2.5 MG SUSPENSION is a brand product labeled by Covis Pharma US, Inc, priced at $14.7250 per EA under NDC 70515062501. Its NADAC has been published 275 times since Feb 19, 2020.
FDA first approved this application on Mar 20, 2008.
The High Outlier badge above means this manufacturer's average price in the omeprazole magnesium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
Covis Pharma US, IncNDC
70515062501
Classification
Brand
Dosage Form
GRANULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OMEPRAZOLE MAGNESIUMApproval Type
New Drug (NDA)
FDA Application
NDA022056FDA Approved
3/20/2008
On Market Since
8/25/2017
Pharmacological Classes
Price Statistics
The NADAC for PRILOSEC DR 2.5 MG SUSPENSION has been published 275 times since Feb 19, 2020, and over the history we have for it it has risen 29.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.7250 per EA |
|---|---|
| All-time high | $14.8224 (Jun 10, 2026) |
| All-time low | $11.4044 (Feb 19, 2020) |
| 52-week high | $14.8224 |
| 52-week low | $14.3695 |
| Median price | $13.2902 |
| Average price | $13.2529 |
| Largest weekly change | +9.9% (Jan 5, 2022) |
| Weeks tracked | 275 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the omeprazole magnesium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRILOSEC DR 2.5 MG SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for PRILOSEC DR 2.5 MG SUSPENSION, manufactured by Covis Pharma US, Inc, is $14.7250 per EA (NDC 70515062501), effective Aug 19, 2026.
How has the price of PRILOSEC DR 2.5 MG SUSPENSION changed over time?
Over the history we have for it, the NADAC for PRILOSEC DR 2.5 MG SUSPENSION has risen 29.1%. It has been tracked across 275 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for PRILOSEC DR 2.5 MG SUSPENSION?
Since Feb 19, 2020, the NADAC for PRILOSEC DR 2.5 MG SUSPENSION has ranged from a low of $11.4044 (Feb 19, 2020) to a high of $14.8224 (Jun 10, 2026), with a median of $13.2902 per EA.
Are there cheaper alternatives to PRILOSEC DR 2.5 MG SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of PRILOSEC DR 2.5 MG SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PRILOSEC DR 2.5 MG SUSPENSION?
PRILOSEC DR 2.5 MG SUSPENSION (NDC 70515062501) is labeled by Covis Pharma US, Inc, and CMS classifies it as a brand product.